CNS Pharmaceuticals, Inc. (CNSP)

Nasdaq: CNSP · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2018

Grade4.1

◀ Past 3.1● Present 2.4▶ Future 6.2

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Report filed	Mar 31, 2026	Mar 31, 2025	Apr 1, 2024	Mar 31, 2023	Mar 3, 2022	Feb 12, 2021	Mar 12, 2020	·
For lenders
Interest and dividend income	·	·	27,687	0	·	·	·	·
Research and development	9,771,940	9,290,143	14,095,606	9,300,055	9,805,075^r	5,061,734	1,854,334	21,267
General and administrative	6,214,619	5,611,800	4,769,502	5,967,052	4,680,840	4,392,873	1,978,643	860,520
Total operating expenses	15,986,559	14,901,943	18,865,108	15,267,107	14,485,915^r	9,454,607	3,832,977	881,787
Operating income	-15,986,559	-14,901,943	-18,865,108	-15,267,107	-14,485,915^r	-9,454,607	-3,832,977	-881,787
Interest expense	15,230	16,120	13,805	7,027	9,285	3,264	26,152	28,615
Total non-operating income (expense)	135,995	44,142	13,882	-7,027	-9,285	-3,264	-44,234	-6,510,112
Income tax expense	0	0	0	0	0	0	0	0
Net income	-15,850,564	-14,857,801	-18,851,226	-15,274,134	-14,495,200^r	-9,457,871	-3,877,211	-7,391,899
Earnings per share, basic	-35.75	-466.89^r	-150,109.32^rb	-336,600.00^b	-495,000.00^b	·	·	·
Earnings per share, diluted	-35.75	-466.89^r	-150,109.32^rb	-336,600.00^b	-495,000.00^b	·	·	·
Earnings per share, basic and diluted	·	·	·	·	-15,900.00^b	-17,100.00^b	-8,400.00^b	-21,000.00^b
Weighted average shares, basic	443,369	31,823^r	126^rb	45^b	29^b	·	·	·
Weighted average shares, diluted	443,369	31,823^r	126^rb	45^b	29^b	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	878^b	554^b	455^b	350^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-12 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Interest and dividend income what its loans and securities earnedus-gaap:InterestIncomeOperating

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton CNSP · research, not advice